Navigation Links
Blood Marker Suggests Severity of Alzheimer's Disease
Date:4/5/2011

By Randy Dotinga
HealthDay Reporter

TUESDAY, April 5 (HealthDay News) -- New research shows that levels of a particular protein can indicate the severity of Alzheimer's disease, but it doesn't serve as an early warning sign of the illness.

Still, the findings are helpful because they reveal that signs of Alzheimer's lurk in the blood, said one of the co-authors of the study.

"What's promising is that we can get such clear signals" through an indicator known as a biomarker, said Monique Breteler, an epidemiologist with University Medical Center Rotterdam in the Netherlands. "It will be a matter of time, and resources, to find the markers or panels of markers in blood that can be used to help predict or diagnose the disease."

Alzheimer's disease, which robs its victims of their memories, affects an estimated 5.2 million people in the United States. That number is expected to grow to as many as 7.7 million Americans by 2030 as the population ages.

At the moment, physicians can't diagnose Alzheimer's with certainty in living patients; it can only be diagnosed with certainty after death.

Scientists have known for some time that there are higher levels of a protein called clusterin in the blood of people with Alzheimer's, Breteler said, and recent research has linked variations in the protein to the disease. Those findings, in turn, raise the prospect that the protein could actually be a factor in causing Alzheimer's, she said. If so, physicians might be able to diagnose the disease early on and maybe even try to stop it in its tracks.

Unfortunately, the new study revealed the limitations of clusterin testing.

From 1997-99, researchers tested levels of the protein in 60 people with Alzheimer's and a randomly chosen group of 926 people, and additionally, in 156 people diagnosed with Alzheimer's before 2007. They found that those with the highest levels of clusterin were also most likely to have Alzheimer's even after they adjusted statistics so they wouldn't be thrown off by factors such as age, education level and gender. Alzheimer's patients with the highest levels had the worst disease.

At the moment, one potential use for a clusterin blood test would be to predict rapid decline in Alzheimer's patients, said Greg Cole, associate director of the Alzheimer's Center at the University of California Los Angeles. "But," he said, "I don't think it is ready for that use."

Dr. James R. Burke, director of the Memory Disorders Clinic at Duke University Medical Center, identified a potential problem with such a test: clusterin levels don't specify whether a person has Alzheimer's disease or vascular dementia, a form of senility related to impaired blood flow, Burke said. "So, measurements of clusterin do not appear to be useful clinically," he noted.

Even so, research like this latest study is "important to prevent widespread adoption of tests that are not useful to answer clinical questions, such as, 'Am I going to get Alzheimer's disease?'" he added.

The study appears in the April 6 issue of the Journal of the American Medical Association.

More information

For more about Alzheimer's disease, try the U.S. National Library of Medicine.

SOURCES: Monique M.B. Breteler, M.D., Ph.D., epidemiologist, University Medical Center Rotterdam, Netherlands; Greg Cole, Ph.D., professor, medicine and neurology, and associate director, Alzheimer's Center, University of California at Los Angeles, and associate director, research, Geriatric Research, Education and Clinical Center, Greater Los Angeles Veterans Administration System; James R. Burke, M.D., Ph.D., director, Memory Disorders Clinic, and associate professor, medicine, Duke University Medical Center, Durham, N.C.; April 6, 2011, Journal of the American Medical Association


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Device drops blood pressure in patients with difficult-to-treat hypertension
2. Dangerous blood pressure increases during exercise can be blocked, UT Southwestern researchers find
3. Blood Test Holds Hope for Spotting Lung Cancer in Nonsmokers
4. University of Cincinnati team to track tumor DNA through bloodstream
5. CDC issues updated bloodstream infection prevention guidelines
6. Remove childrens catheters as soon as possible to prevent bloodstream infections
7. Case study reports singing lowers patients blood pressure prior to surgery
8. Nerve Block Treatment May Ease Stubborn High Blood Pressure
9. High Blood Pressure in Docs Office Not Always Hypertension
10. Nicotine Raises Blood Sugar Levels in Lab
11. Laughter, Music May Lower Blood Pressure, Study Says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Marker Suggests Severity of Alzheimer's Disease
(Date:4/25/2017)... ... , ... Lake Park Dental is now accepting new patients with crooked teeth ... With the help of this highly-effective, yet convenient system, patients can straighten their teeth ... less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, ...
(Date:4/25/2017)... ... ... Back Pain Centers of America (BPC), which connects people searching ... area, announces the launch of a new and proprietary customer relationship management (CRM) system ... physicians to help them with back or neck pain and helps to match them ...
(Date:4/25/2017)... Ariz. (PRWEB) , ... April 25, 2017 , ... Emergency ... latest book of the Outlier Leadership Series, Outliers in Writing, set to publish in ... Professor of Emergency Medicine at the University of Arizona College of Medicine. He also ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Emmanuel College ... busy nursing professionals advance their careers. Beginning in the fall of 2017, Emmanuel’s program ... degree in as few as 16 months and for as little as $14,528. These ...
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a ... new strategies to reduce waste, and support renewable energy. They believe this is a ... nature to find solutions for health issues, and maintain that destroying the environment in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
Breaking Medicine Technology: